News | July 11, 2013

Doctors Implant Impella pLVAD to Treat Ailing Country Music Star

July 11, 2013 — Abiomed’s Impella percutaneous left ventricular assist device (pLVAD) was recently deployed at Baylor Medical Center in McKinney, Texas, to treat country music singer Randy Travis, said publicist Kirt Webster in a statement this week.

Travis was admitted July 7 with a “presumptive cardiomyopathy and congestive heart failure,” said William Gray, DO, FACC, director of cardiovascular services at Baylor Medical Center, in a video statement released on Baylor’s website.

Impella pumps are available in a variety of sizes and models. Delivered percutaneously during minimally invasive procedures, they deliver partial circulatory support for patients suffering from a range of heart problems. Though cost concerns remain, it is believed pLVADs may challenge intra-aortic balloon pumps (IABPs) when it comes to hemodynamic support.

The Impella LVAD was placed in the patient’s heart before he was transferred to The Baylor Heart Hospital in Plano on July 8. Since then he has suffered a stroke as a complication of the congestive heart failure, said Baylor physicians in a statement on the hospital’s website. He is currently in critical condition.

For more information: www.baylorhealth.com

Related Content

Cardiogenic Shock Survival Rates Improve in Three Years Since Impella FDA Approval
News | Ventricular Assist Devices (VAD) | April 05, 2019
Three years ago this week, Abiomed's Impella heart pump received U.S. Food and Drug Administration (FDA) premarket...
HeartMate 3 Pump Shows Superior Outcomes in Advanced Heart Failure
News | Ventricular Assist Devices (VAD) | March 22, 2019
Severely ill patients with advanced heart failure who received the HeartMate 3 left ventricular assist device (LVAD)...
Leviticus Cardio and Jarvik Heart Unveil Wireless Heart Pump System
News | Ventricular Assist Devices (VAD) | February 11, 2019
Heart failure experts at the National Research Center for Cardiac Surgery in Astana, Kazakhstan, recently announced the...
Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure
Technology | Ventricular Assist Devices (VAD) | July 17, 2018
Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive implant approach...
CorWave's Next-generation Neptune LVAD Receives Funding

Image courtesy of CorWave

News | Ventricular Assist Devices (VAD) | July 11, 2018
French-based CorWave announced that its CALYPSO program has received 14 million euros to develop CorWave Neptune, a new...
Abbott Recalls the HeartMate 3 Left Ventricular Assist System, LVAD
News | Ventricular Assist Devices (VAD) | May 23, 2018
Abbott has initiated a Class I recall of the HeartMate 3 Left Ventricular Assist System due to a malfunction in the...
FDA Approves Abiomed Impella CP With SmartAssist and Optical Sensor
Technology | Ventricular Assist Devices (VAD) | April 02, 2018
Abiomed Inc. announced that it received U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for its...
Reduced Device Clotting, Decreased Strokes Seen With HeartMate 3 at Two Years
News | Ventricular Assist Devices (VAD) | March 13, 2018
At two years of follow-up, severely ill patients with advanced heart failure who received a novel heart pump fully...
Medtronic HeartWare HVAD System Approved for Destination Therapy
Technology | Ventricular Assist Devices (VAD) | October 04, 2017
October 4, 2017 — Medtronic received U.S.
Overlay Init